v3.25.2
Earning (Loss) Per Share - Schedule of Ordinary Shares Equivalents Were Excluded from the Computation to Eliminate Any Antidilutive Effect (Details) - $ / shares
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Warrant [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Ordinary shares equivalents were excluded from the computation to eliminate any antidilutive effect [1] $ 16,500,000
Ordinary shares Placed in Escrow [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Ordinary shares equivalents were excluded from the computation to eliminate any antidilutive effect [2] $ 4,328,394
[1] For the years ended March 31, 2025, 2024, and 2023, the Company had the 16,500,000, 0, and 0 shares of warrants, respectively, outstanding which were not included in the calculation of diluted net (income) loss per ordinary share because inclusion thereof would be anti-dilutive
[2] For the years ended March 31, 2025, 2024, and 2023, the Company had 4,328,394, 0, and 0 ordinary shares, respectively, held in escrow. The Company has determined that these shares are non-participating securities in accordance with ASC 260, as they are not entitled to dividends or other rights until certain milestones are met. As such, these shares are excluded from the calculation of basic and diluted earnings (loss) per share for the respective periods.